Tower Research Capital LLC (Trc) Night Hawk Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.15 - $0.45 $69 - $208	464 Added 6.97%	7,123 $1,000
Q4 2023 Feb 13, 2024	SELL	$0.26 - $0.51 $49 - $97	-191 Reduced 2.79%	6,659 $2,000
Q3 2023 Nov 14, 2023	SELL	$0.5 - $0.72 $30 - $43	-60 Reduced 0.87%	6,850 $3,000
Q2 2023 Aug 14, 2023	SELL	$0.62 - $0.87 $1,540 - $2,161	-2,485 Reduced 26.45%	6,910 $4,000
Q1 2023 May 09, 2023	BUY	$0.83 - $1.24 $1,171 - $1,750	1,412 Added 17.69%	9,395 $8,000
Q4 2022 Feb 10, 2023	BUY	$0.77 - $1.62 $2,572 - $5,412	3,341 Added 71.97%	7,983 $6,000
Q3 2022 Nov 10, 2022	BUY	$1.79 - $2.96 $8,160 - $13,494	4,559 Added 5492.77%	4,642 $8,000
Q1 2022 May 12, 2022	SELL	$2.1 - $3.54 $20,645 - $34,801	-9,831 Reduced 99.16%	83 $0
Q4 2021 Feb 14, 2022	BUY	$3.04 - $6.01 $30,138 - $59,583	9,914 New	9,914 $30,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.